GNH USA

Europe — EMA

Icomas

GNH USA supplies Icomas (Methane, Acetylene, Carbon Monoxide), a gaseous formulation of inorganic compounds. Request a quote for global supply to you.

Methane, Acetylene, Carbon Monoxide

Request sourcing

1
Pack/s

What is Methane, Acetylene, Carbon Monoxide?

Methane, the active ingredient in Icomas, is an inorganic gas presented as an inhalation formulation for inhalation use. It has no established therapeutic indication in clinical practice.

GNH USA supplies Icomas as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methane, Acetylene, Carbon Monoxide used for?

Icomas currently has no recognized therapeutic indications in clinical practice.

What are the side effects of Methane, Acetylene, Carbon Monoxide?

Adverse reactions reported for inhalation of the constituent gases are limited and largely related to exposure concentration.

Common Side Effects: - Respiratory tract irritation: mild coughing or throat discomfort. - Headache: transient sensation often reported after exposure. - Dizziness: occasional light‑headedness during or after inhalation.

Serious or Rare Side Effects: - Carbon monoxide poisoning: symptoms include nausea, confusion, and loss of consciousness. - Severe hypoxia: reduced oxygen delivery leading to cyanosis. - Acute pulmonary edema: fluid accumulation in lungs in extreme exposure. - Loss of consciousness: sudden fainting due to hypoxic effects. - Cardiac arrhythmia: irregular heart rhythm in susceptible individuals.

What precautions apply to Methane, Acetylene, Carbon Monoxide?

When handling Icomas, consider the following safety measures. - Avoid use in patients with chronic respiratory disease: increased risk of irritation and hypoxia. - Do not exceed recommended exposure limits: high concentrations can be toxic. - Monitor for signs of carbon monoxide exposure: headache, nausea, or visual disturbances. - Use only under professional supervision: ensure proper ventilation and equipment. - Store at ambient temperature: keep container sealed, protect from heat, open flame and direct sunlight.

What does Methane, Acetylene, Carbon Monoxide interact with?

Potential interactions with other inhaled or systemic agents should be evaluated.

Major Interactions (Avoid): - Nitrous oxide: additive central nervous system depression. - Benzodiazepines: increased sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Supplemental oxygen therapy: may alter gas concentration and efficacy. - General anesthetic agents: potential synergistic respiratory effects. - Anticoagulants: theoretical risk of altered platelet function with high‑dose acetylene exposure.

Frequently asked questions

What is Icomas used for?+
Icomas is a gaseous formulation containing methane, acetylene and carbon monoxide. At present it has no approved therapeutic indication and is not used in standard clinical practice. Its primary presence in the market is as a chemical product, and any investigational use would be limited to research settings under strict regulatory oversight.
How does methane, the main ingredient in Icomas, work?+
Methane is an inert hydrocarbon gas that does not bind to specific human receptors. When inhaled, it can dilute oxygen in the airway, potentially leading to hypoxic effects at high concentrations. Its pharmacological activity is not defined, and any physiological impact is largely related to physical displacement of oxygen rather than a targeted biochemical mechanism.
What is the usual dose of Icomas?+
The dosage of Icomas is determined by the prescribing healthcare professional based on the specific clinical context, if any. Because the product does not have an established therapeutic dose, prescribers must define the amount, concentration and duration of inhalation according to local regulations and safety guidelines.
Is Icomas safe to use during pregnancy or breastfeeding?+
There is no safety data for Icomas in pregnant or lactating individuals. The constituent gases, especially carbon monoxide, can cross the placenta and be secreted in breast milk, posing potential risks to the fetus or infant. Until reliable studies are available, use is not recommended in these populations.
How do I order Icomas from GNH USA?+
To place an order, visit the product page on gnh-usa.com, enter the required quantity, and submit the enquiry form. GNH USA supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.
How does Icomas compare with other inhaled therapies?+
Unlike conventional inhaled medicines such as bronchodilators or corticosteroids, Icomas contains inorganic gases without a defined therapeutic target. Established inhaled therapies act on specific receptors to relieve airway obstruction or inflammation, whereas Icomas lacks such pharmacodynamic properties and is not approved for medical treatment.
What are the storage and handling requirements for Icomas?+
Icomas should be stored at ambient temperature, away from direct sunlight, heat sources and open flames. Keep the container tightly sealed in its original packaging to prevent gas leakage. Ensure the storage area is well‑ventilated and that personnel handling the product wear appropriate protective equipment.
How is Icomas administered?+
Icomas is supplied as an inhalation product intended for delivery via a calibrated gas‑delivery system. Administration involves controlled release of the gas mixture into the breathing circuit under professional supervision, with continuous monitoring of the patient’s respiratory status and ambient oxygen levels.
What are the most serious risks associated with Icomas?+
The most serious risks stem from carbon monoxide toxicity, which can cause headache, nausea, loss of consciousness, and potentially fatal hypoxia. High concentrations of the gas mixture may also lead to severe respiratory irritation, pulmonary edema, and cardiac arrhythmias, especially in vulnerable individuals.
Who should not use Icomas?+
Icomas should not be used by individuals with known respiratory disorders, cardiovascular disease, or any condition that predisposes them to hypoxia. It is also contraindicated for pregnant or breastfeeding persons, children, and anyone lacking professional medical supervision during exposure.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methane, Acetylene, Carbon Monoxide
Route
Inhalation Use
Manufacturer
Linde Sverige Ab
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU